Clinical Trial Update: Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing zoledronic acid with alendronate in postmenopausal osteoporosis assessed safety and effects on bone metabolism; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)
• alendronate (alendronate)

Snippet

Sponsor: Novartis | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2011-07-01